Zobrazeno 1 - 10
of 10
pro vyhledávání: '"E. V. Shorikov"'
Autor:
G. A. Tsaur, T. V. Nasedkina, A. M. Popov, O. V. Kalennik, A. G. Solodovnikov, T. O. Riger, Yu. A. Yakovleva, A. S. Ivanova, A. E. Druy, O. M. Plekhanova, E. V. Shorikov, L. I. Saveliev, L. G. Fechina
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 46-54 (2022)
Early therapy response is one of the major prognostic factors influencing an outcome of acute lymphoblastic leukemia (ALL). The purpose of the given work was to define a time point (TP) of fusion gene transcript (FGt) monitoring by reverse-transcript
Externí odkaz:
https://doaj.org/article/bccdae5e6fb84086b30c2fa0980c4bf2
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 1, Pp 134-136 (2019)
Functional diagnostics method (scintigraphy), connected with injection of radioactive isotopes with further getting of 2-D image by emitting radiation detection, is widely used in medicine. Scintigraphic visualization of infections and inflammation w
Externí odkaz:
https://doaj.org/article/5f912c62412749349291aa49badf28a2
Autor:
G. A. Tsaur, A. Е. Druy, A. G. Solodonikov, A. M. Popov, A. P. Shapochnik, L. V. Vakhonina, А. А. Vlasova, Т. О. Riger, T. Yu. Verzhbitskaya, Yu. V. Olshanskaya, E. V. Shorikov, О. R. Arakaev, L. I. Saveliev, L. G. Fechina
Publikováno v:
Онкогематология, Vol 11, Iss 4, Pp 32-48 (2017)
We assessed the prognostic significance of IKZF1 gene deletions in 141 pediatric patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) on Russian multicenter trial in pediatric clinics of Ekaterinburg and Orenburg. IKZF1 deletions wer
Externí odkaz:
https://doaj.org/article/36ad7a46204148478389e7030c892069
Autor:
A. M. Popov, Y. Yu. Verzhbitskaya, G. A. Tsaur, A. G. Solodovnikov, O. R. Arakaev, O. V. Streneva, O. P Khlebnikova, E. V. Shorikov, L. I. Saveliev, S. N. Lagoyko, Yu. V. Rumyantseva, A. I. Karachunskiy, L. G. Fechina
Publikováno v:
Онкогематология, Vol 10, Iss 4, Pp 44-55 (2015)
191 consecutive unselected children with acute lymphoblastic leukemia aged from 1 to 16 years were enrolled in the study. Bone marrow samples were obtained at the time of initial diagnostics as well as at days 15 (n = 188), 36 (n = 191), and 85 (n =
Externí odkaz:
https://doaj.org/article/0218a3540de14fb58723611f40943264
Autor:
G. A. Tsaur, A. M. Popov, O. V. Aleynikova, E. G. Boychenko, T. Yu. Verzhbitskaya, E. V. Volochnik, A. S. Ivanova, O. V. Kalennik, S. Yu. Kovalev, K. L. Kondtratchik, A. M. Kustanovich, E. S. Lapotentova, D. V. Litvinov, I. S. Martynkevich, N. V. Myakova, T. V. Nasedkina, V. A. Ovsepyan, Yu. V. Olshanskaya, O. M. Plehanova, A. V. Popa, T. O. Riger, L. I. Savelyev, O. V. Streneva, M. V. Strigaleva, I. V. Shmunk, E. V. Shorikov, L. G. Fechina
Publikováno v:
Онкогематология, Vol 6, Iss 3, Pp 57-64 (2014)
117 cases of infant acute lymphoblastic leukemia without Down syndrome (aged from 1 to 365 days) were included in the current study.Rearrangements of 11q23 (MLL) were revealed in 74 (63.2 %) patients. Among this group the most common rearrangement wa
Externí odkaz:
https://doaj.org/article/a38eecadd7c84ecc9537c84830839adc
Autor:
A. M. Popov, G. A. Tsaur, T. Yu. Verzhbitskaya, O. V. Streneva, E. V. Shorikov, L. I. Saveliev, L. G. Fechina
Publikováno v:
Онкогематология, Vol 7, Iss 2, Pp 14-24 (2014)
Aim of the study – immunophenotype description of infant acute lymphoblastic leukemia (ALL). 64 patients (29 boys and 35 girls) with acute leukemia (AL) aged from 0 to 11 months were included in the current study. ALL was found less frequently in i
Externí odkaz:
https://doaj.org/article/ec102b881d0f44e08af0f38f9dacf9ad
Autor:
A. M. Popov, G. A. Tsaur, T. Yu. Verzhbitskaya, O. V. Streneva, E. V. Shorikov, L. I. Saveliev, L. G. Fechina
Publikováno v:
Онкогематология, Vol 8, Iss 1, Pp 33-39 (2014)
Aim of the study – characterization of immunophenotype in infant acute myeloid leukemia (AML). 90 patients (40 boys and 50 girls) with acute leukemia (AL) aged up to 365 days were included in the current study. AML was found more frequently in infa
Externí odkaz:
https://doaj.org/article/ecdea07ef7e142fd86128cd15e46cedd
Autor:
G. A. Tsaur, A. Е. Druy, A. G. Solodonikov, A. M. Popov, A. P. Shapochnik, L. V. Vakhonina, А. А. Vlasova, Т. О. Riger, T. Yu. Verzhbitskaya, Yu. V. Olshanskaya, E. V. Shorikov, О. R. Arakaev, L. I. Saveliev, L. G. Fechina
Publikováno v:
Onkogematologiâ, Vol 11, Iss 4, Pp 32-48 (2017)
We assessed the prognostic significance of IKZF1 gene deletions in 141 pediatric patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) on Russian multicenter trial in pediatric clinics of Ekaterinburg and Orenburg. IKZF1 deletions wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398557c60c4a0563666bd13ea7996c3a
https://doi.org/10.17650/1818-8346-2016-11-4-32-48
https://doi.org/10.17650/1818-8346-2016-11-4-32-48
Autor:
G. A. Tsaur, A. M. Popov, O. V. Aleynikova, E. G. Boychenko, T. Yu. Verzhbitskaya, E. V. Volochnik, A. S. Ivanova, O. V. Kalennik, S. Yu. Kovalev, K. L. Kondtratchik, A. M. Kustanovich, E. S. Lapotentova, D. V. Litvinov, I. S. Martynkevich, N. V. Myakova, T. V. Nasedkina, V. A. Ovsepyan, Yu. V. Olshanskaya, O. M. Plehanova, A. V. Popa, T. O. Riger, L. I. Savelyev, O. V. Streneva, M. V. Strigaleva, I. V. Shmunk, E. V. Shorikov, L. G. Fechina
Publikováno v:
Onkogematologiâ, Vol 6, Iss 3, Pp 57-64 (2014)
117 cases of infant acute lymphoblastic leukemia without Down syndrome (aged from 1 to 365 days) were included in the current study. Rearrangements of 11q23 (MLL) were revealed in 74 (63.2 %) patients. Among this group the most common rearrangement w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::faf3644e23b2106acd7e4dd199cad56d
http://cyberleninka.ru/article/n/detection-of-11q23-mll-rearrangements-in-infant-acute-lymphoblastic-leukemia
http://cyberleninka.ru/article/n/detection-of-11q23-mll-rearrangements-in-infant-acute-lymphoblastic-leukemia
Autor:
Jun Liu, Cuicui Li, Xu Yang, Xia Lu, Mingyu Zhang, Luodan Qian, Wei Wang, Ying Kan, Jigang Yang
Publikováno v:
Contrast Media & Molecular Imaging; 1/6/2022, p1-9, 9p